35 studies found for:    " October 13, 2010":" November 12, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" October 13, 2010":" November 12, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
Conditions: Chronic HIV Infection;   HCV Coinfection
Intervention: Drug: Fosamprenavir
2 Withdrawn Depot Contraception With and Without Lopinavir/Ritonavir
Condition: HIV Infection
Intervention: Drug: DMPA
3 Unknown  Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT)
Conditions: HIV Infection;   Acquired Immunodeficiency Syndrome
Interventions: Drug: Protease Inhibitor;   Drug: Standard-of-care Antiretroviral therapy
4 Completed Pharmacokinetic Interactions Between an Herbal Medicine (African Potato) and Antiretroviral Agents (Lopinavir/Ritonavir)
Conditions: Drug Interactions;   Human Immunodeficiency Virus
Intervention: Drug: Kaletra (lopinavir/ritonavir), African Potato (hypoxis obtusa)
5 Terminated Dose-finding Study of GSK2248761 in Antiretroviral Therapy-Naive Subjects (SIGNET)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761 100 mg once daily;   Drug: GSK2248761 200 mg once daily;   Drug: Efavirenz 600 mg once daily
6 Active, not recruiting
Has Results
A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: GSK1349572 (dolutegravir);   Drug: raltegravir;   Other: GSK1349572 Placebo;   Other: ABC/3TC;   Other: TDF/FTC;   Other: raltegravir Placebo
7 Completed Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting
Condition: HIV
8 Unknown  Vaginal Innate Immunity in Normal and HIV-Infected Women
Conditions: HIV;   Pregnancy
Intervention: Other: Vaginal lavage specimen
9 Completed IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l Sites
Conditions: IRIS;   HIV
10 Enrolling by invitation IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents
Conditions: ADHD;   HIV
11 Active, not recruiting Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
Conditions: HIV;   Hepatitis C;   Liver Fibrosis
Interventions: Drug: Raltegravir;   Drug: Ritonavir-boosted protease inhibitor
12 Completed Young Women's CoOp Study
Conditions: HIV;   Sexual Risk;   Sexually Transmitted Diseases;   Substance Abuse;   Violence;   Victimization
Interventions: Behavioral: Young Women's CoOp;   Behavioral: Staying Healthy and Eating Well
13 Completed Study Targeting Affect Regulation
Conditions: HIV;   AIDS;   Substance Use Disorders
Intervention: Behavioral: Resilient Affective Processing Therapy (RAPT)
14 Completed Prevention of HIV and STDs in Drug Using Women
Conditions: HIV;   Sexually Transmitted Diseases;   Substance Abuse
Interventions: Behavioral: NIDA Cooperative Agreement Standard Intervention plus HIV/STD testing;   Behavioral: Standard Intervention plus Well-Woman Exam;   Behavioral: Standard Intervention plus Well-Woman Exam and Peer-Delivered Intervention
15 Completed Multi-vitamins, HAART and HIV/AIDS in Uganda
Condition: HIV/AIDS
Intervention: Dietary Supplement: Multivitamin supplements B,C and E
16 Active, not recruiting Study to Improve Survival Among HIV-Exposed Infants in Botswana
Conditions: HIV Infections;   Neutropenia;   Anemia
Interventions: Drug: cotrimoxazole prophylaxis;   Drug: cotrimoxazole placebo;   Behavioral: exclusive breastfeeding until 6 months of age;   Behavioral: breastfeeding for 12 months
17 Completed Non-virologic Methods to Diagnose Treatment Eligibility in HIV-exposed Infants
Condition: HIV Infections
18 Active, not recruiting Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV)
Conditions: HIV Infection;   Bone Loss;   Osteopenia;   Osteoporosis
Intervention: Drug: Zoledronic acid
19 Completed Acceptability Study of Vaginal Films for HIV Prevention
Conditions: HIV Infections;   Anti-Infective Agents
Intervention: Other: No intervention (not applicable)
20 Completed Post-Exposure Prophylaxis in Health Care Workers
Condition: Human Immunodeficiency Virus
Intervention: Drug: emtricitabine/tenofovir disoproxil fumarate

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Indicates status has not been verified in more than two years